BIOTEST AG ST O.N./ DE0005227201 /
2024-04-25 8:20:01 AM | Chg. -0.2000 | Volume | Bid2:30:05 PM | Ask2:30:05 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
41.0000EUR | -0.49% | 0 Turnover: 0.0000 |
41.0000Bid Size: 100 | 41.8000Ask Size: 100 | 1.62 bill.EUR | 0.10% | - |
GlobeNewswire
2021-12-03
Marizyme Inc. Announces Results of GOAL Study Presented at 7th Annual International Coronary Congres...
GlobeNewswire
2021-08-09
ADMA Biologics Announces Commercial Availability of Expanded Vial Size Offerings for BIVIGAM® and NA...
GlobeNewswire
2021-04-13
ADMA Biologics Announces Poster Presentation Highlighting Pharmacoeconomic Burden of HIV and HBV Inf...
GlobeNewswire
2020-12-09
ADMA Biologics Enters Into $100 Million Credit Facility Loan Amendment with Perceptive Advisors
GlobeNewswire
2019-10-10
2019 Italian Molecular Diagnostic Analyzers and Reagent Forecasts for 100 Tests: Supplier Shares, Vo...
GlobeNewswire
2019-10-10
Canada Molecular Diagnostic Analyzers and Reagent Forecasts for 100 Tests: Supplier Shares and Strat...
GlobeNewswire
2019-10-10
United Arab Emirates Molecular Diagnostic Analyzers and Reagent Forecasts for 100 Tests 2019: Suppli...
GlobeNewswire
2019-10-10
Bahrain Molecular Diagnostic Analyzers and Reagent Forecasts for 100 Tests, 2019: Infectious and Gen...
GlobeNewswire
2019-10-10
Cyprus Nucleic Acid Testing Market for 100 Assays, 2019: Companies Such as Arca Biopharma, Diadexus ...
GlobeNewswire
2019-10-10
South Korean Nucleic Acid Testing Market for 100 Assays: Five-year test volume and sales forecasts
GlobeNewswire
2019-10-10
2019 Kuwait Nucleic Acid Testing Market for 100 Assays: Supplier Shares and Strategies, Country Volu...
GlobeNewswire
2019-10-10
Malta Nucleic Acid Testing Market for 100 Assays: Infectious and Genetic Diseases, Cancer, Forensic ...
GlobeNewswire
2019-08-22
ADMA Biologics Announces Commercial Relaunch and its First Commercial Sales of BIVIGAM®
GlobeNewswire
2019-08-08
ADMA Biologics Reports Second Quarter and First Half 2019 Financial Results
GlobeNewswire
2019-07-08
ADMA Biologics Receives FDA Approval for License Transfers for BIVIGAM® and Nabi-HB®
GlobeNewswire
2019-05-03
ADMA Biologics Elects to Draw-Down $27.5 Million in Capital from Existing Perceptive Advisors Credi...
GlobeNewswire
2019-05-02
2019 Nucleic Acid Testing Market Competitive Landscape: Strategic Assessments of Leading Suppliers